Stock TDOC TELADOC HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-24 pm EDT 		5-day change 1st Jan Change
13.73 USD -0.07% Intraday chart for Teladoc Health, Inc. +4.49% -36.29%
Apr. 12 Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024 CI
Apr. 08 Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating MT

Evolution of the average Target Price on Teladoc Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

26b0a8b785d73982b2.8c9ubBKWcUP9szx8b6ozm3EvNDe2T8lhtDgaX-yMAoo.qbVWCXakNgrL9wo4IscHz0Z2R0XOCv0z1nNxLI-7bdihhEM7WN02NsnlDA~5fb63b267db2a5bdd2713bc54b6ea454

Analyst Recommendations on Teladoc Health, Inc.

Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating MT
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating MT
Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating MT
Canaccord Genuity Lowers Price Target on Teladoc to $28 From $34, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Teladoc to $25 From $30, Maintains Overweight Rating MT
RBC Cuts Price Target on Teladoc to $25 From $30, Notes 'Slower Expected Revenue Trajectory,' Keeps Outperform Rating MT
JPMorgan Adjusts Price Target on Teladoc to $19 From $33, Maintains Neutral Rating MT
UBS Adjusts Teladoc Price Target to $20 From $28, Maintains Neutral Rating MT
Deutsche Bank Adjusts Teladoc Price Target to $23 From $29, Maintains Hold Rating MT
Oppenheimer Adjusts Teladoc Price Target to $26 From $35, Maintains Outperform Rating MT
RBC Cuts Price Target on Teladoc to $30 From $35, Keeps Outperform Rating MT
Citigroup Cuts Price Target on Teladoc to $21 From $29, Keeps Neutral Rating MT
Evercore ISI Raises Teladoc's Price Target to $25 From $23, In Line Rating Kept MT
Citigroup Cuts Teladoc's Price Target to $29 From $31, Neutral Rating Kept MT
UBS Adjusts Teladoc Price Target to $28 From $30, Maintains Neutral Rating MT
Deutsche Bank Adjusts Teladoc Price Target to $29 From $27, Maintains Hold Rating MT
UBS Raises Teladoc Price Target to $30 From $29, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Teladoc to $29 From $28, Keeps Equalweight Rating MT
Stephens Initiates Teladoc at Equalweight With $25 Price Target MT
Credit Suisse Lowers Teladoc's Price Target to $27 From $30, Keeps Neutral Rating MT
Canaccord Genuity Trims Price Target on Teladoc to $36 From $40, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Teladoc to $23 From $28, Maintains Equal-Weight Rating MT
UBS Adjusts Teladoc Price Target to $29 From $32, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
13.73 USD
Average target price
19.51 USD
Spread / Average Target
+42.12%
High Price Target
28 USD
Spread / Highest target
+103.93%
Low Price Target
15 USD
Spread / Lowest Target
+9.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Teladoc Health, Inc.

Deutsche Bank Securities
Leerink Partners
Citigroup
Barclays
Piper Sandler
Canaccord Genuity
RBC Capital Markets
JPMorgan Chase
UBS
Oppenheimer
Evercore ISI
Stephens Inc.
Credit Suisse
Wells Fargo Securities
SVB Securities LLC
Berenberg Bank
DA Davidson
Guggenheim
Truist Securities
KeyBanc Capital Markets
Cowen
Needham & Co.
Goldman Sachs
Stifel Nicolaus
Argus
SVB Leerink
Baird
William Blair & Co.
Craig-Hallum
Jefferies & Co.
BTIG

Ratings for Teladoc Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TDOC Stock
  4. Consensus Teladoc Health, Inc.